Gastrointestinal Interventions
Gregory Woodhead, MD, PhD
Assistant Professor
University of Arizona, College of Medicine
Disclosure(s): No relevant disclosure to display
Juan Gimenez, MD
Interventional Radiologist
Oschner Health
Disclosure(s): No relevant disclosure to display
A global obesity epidemic is driving a rise in nonalcoholic fatty liver disease (NAFLD). In parallel, NASH cirrhosis is the fasted rising cause of HCC. Accordingly, the practice of IR will need to understand how treating patients with NAFLD may differ from other types of cirrhosis and other causes of HCC. Of note, the desert southwest, including the host state for SIR 2023, Arizona, has two ethnic groups with increased incidence of NAFLD/NASH: Native American and Hispanic populations.
Speaker: Gregory J. Woodhead, MD, PhD – University of Arizona, College of Medicine
Speaker: Gina Landinez, MD (she/her/hers) – Miami Cardiac and Vascular Institute (MCVI) Miami Cancer Institute (MCI)
Speaker: Keith Pereira, MD, DABR, RPVI – Saint Louis University School of Medicine
Speaker: Naim Alkhouri, Chief Medical Officer (he/him/his) – Arizona Liver Health
Speaker: Divya Kumari, MD – University of Chicago Medicine
Speaker: Juan Gimenez, MD – Oschner Health
Speaker: Jack Hannallah, MD, MBA, MPH – University of Arizona
Speaker: Clifford R. Weiss, MD – Department of Radiology, Radiological Science and Biomedical Engineering, Johns Hopkins University School of Medicine
.jpg)
.png)
.png)
.png)
.jpg)
.jpg)
.png)
.png)
.png)